1. Home
  2. ETNB vs SPB Comparison

ETNB vs SPB Comparison

Compare ETNB & SPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETNB
  • SPB
  • Stock Information
  • Founded
  • ETNB 2018
  • SPB 1906
  • Country
  • ETNB United States
  • SPB United States
  • Employees
  • ETNB N/A
  • SPB N/A
  • Industry
  • ETNB Biotechnology: Pharmaceutical Preparations
  • SPB Industrial Machinery/Components
  • Sector
  • ETNB Health Care
  • SPB Miscellaneous
  • Exchange
  • ETNB Nasdaq
  • SPB Nasdaq
  • Market Cap
  • ETNB 1.5B
  • SPB 1.3B
  • IPO Year
  • ETNB 2019
  • SPB N/A
  • Fundamental
  • Price
  • ETNB $9.23
  • SPB $56.59
  • Analyst Decision
  • ETNB Strong Buy
  • SPB Buy
  • Analyst Count
  • ETNB 8
  • SPB 5
  • Target Price
  • ETNB $26.29
  • SPB $83.40
  • AVG Volume (30 Days)
  • ETNB 1.6M
  • SPB 641.9K
  • Earning Date
  • ETNB 08-07-2025
  • SPB 08-07-2025
  • Dividend Yield
  • ETNB N/A
  • SPB 3.32%
  • EPS Growth
  • ETNB N/A
  • SPB N/A
  • EPS
  • ETNB N/A
  • SPB 2.71
  • Revenue
  • ETNB N/A
  • SPB $2,849,200,000.00
  • Revenue This Year
  • ETNB N/A
  • SPB N/A
  • Revenue Next Year
  • ETNB N/A
  • SPB N/A
  • P/E Ratio
  • ETNB N/A
  • SPB $25.74
  • Revenue Growth
  • ETNB N/A
  • SPB N/A
  • 52 Week Low
  • ETNB $4.16
  • SPB $50.73
  • 52 Week High
  • ETNB $11.84
  • SPB $96.62
  • Technical
  • Relative Strength Index (RSI)
  • ETNB 45.00
  • SPB 51.00
  • Support Level
  • ETNB $8.95
  • SPB $55.77
  • Resistance Level
  • ETNB $9.50
  • SPB $59.45
  • Average True Range (ATR)
  • ETNB 0.54
  • SPB 2.09
  • MACD
  • ETNB -0.03
  • SPB 0.28
  • Stochastic Oscillator
  • ETNB 42.60
  • SPB 63.79

About ETNB 89bio Inc.

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).

About SPB Spectrum Brands Holdings Inc.

Spectrum Brands Holdings Inc is consumer products and home essentials company. The company is a supplier of consumer batteries, residential locksets, residential builders' hardware, grooming products and personal care products. The company manages the businesses in product-focused segments; Home and Personal Care, global Pet Care, and Home and Garden. The Company manufactures, markets and distributes its products globally in the North America, Europe, Middle East & Africa, Latin America, and Asia-Pacific.

Share on Social Networks: